This study quantitatively examined reasons for substance use among individuals with psychotic disorders and explored the relationship of these reasons to substance use problems and dependence. Sixty-nine people with psychotic disorders were interviewed using a battery of questionnaires called the Substance Use Scale for Psychosis (SUSP). Symptoms and medication side effects were also measured. A factor analysis revealed similar motives for substance use (mostly alcohol and cannabis use) as in the general population: "enhancement," "social motives," "coping with unpleasant affect," and "conformity and acceptance." A fifth factor, "relief of positive symptoms and side effects," demonstrated limited reliability. "Coping" and "enhancement" motives were found to lead to substance use problems and dependence. Mediator analysis indicated that worse symptoms lead to stronger motives for substance use, which in turn lead to stronger psychological dependence on that substance. These findings have the potential to inform effective treatment for substance use in psychosis.
There has been increasing concern regarding substance use among individuals with psychotic disorders. Australian and U.S. studies indicate that the proportion of the psychotic disordered population that misuses alcohol and illicit substances is higher than the proportion of the general population (Schneier and Siris 1987; Regier et al. 1990; Fowler et al. 1998) . Research indicates a worsening of mental health symptoms in individuals with psychotic disorders who abuse substances, including an increase in psychiatric admission rates (Martinez-Aravelo et al. 1994) ; depressive symptoms and suicidal ideation (Strakowski et al. 1994; Krausz et al. 1996) ; and increased positive symptoms of psychosis (Rolfe et al. 1999 ) such as suspicion (Dixon et al. 1990 ) and grandiose delusions (Strakowski et al. 1994 ). Independent of conjecture about causality, substance use impacts adversely on the course and outcome of psychotic disorders (see Dixon 1999) . Even relatively minor use can be predictive of poor outcome (Zeidonis and Fisher 1994; Kavanagh et al. 1998) . Problematic substance use can therefore occur for this population within a wider range of frequencies and quantities than in the nonpsychiatric population.
Treatments that attempt to help psychotic individuals reduce or abstain from substance use are widespread in the United States and are being developed in Australia (Kavanagh 1995) . Recent reviews (Drake et al. 1998; Siegfried 1998) indicate that the more successful treatments involve cognitive-behavioral approaches such as relapse prevention (Marlatt and Gordon 1985) and motivational interviewing (Miller and Rollnick 1991) . These treatments involve exploring people's motivations for using substances or their expectations of what substance use will achieve.
The success of these treatments requires an understanding of reasons for substance use reported by people with psychotic disorders. Although there may be other factors, such as biological drives, that lead people to use substances (Miller et al. 1994) , self-reported reasons for Send reprint requests to Dr. P. Michie, Discipline of Psychology, School of Behavioural Sciences, University of Newcastle, Callaghan. NSW 2308, Australia; e-mail: Pat. Michie@newcastle.edu.au. use give an understanding of the drives that people are consciously aware of and may inform treatment interventions (Graham 1998) .
Reasons for Substance Use
Numerous qualitative studies have been conducted in North America, Australia, and the United Kingdom investigating self-reported reasons for substance use in patients with psychotic disorders (Test et al. 1989; Dixon et al. 1991; Warner et al. 1994; Baigent et al. 1995; Addington and Duchak 1997; Fowler et al. 1998) . Some protocols involve patients selecting their reasons for use from predetermined lists (Test et al. 1989; Dixon et al. 1991; Warner et al. 1994; Addington and Duchak 1997) , and others ask open-ended questions (Baigent et al. 1995; Fowler et al. 1998 ). Despite differences in methodology, results are similar and indicate three main motives for substance use, regardless of the substance type: (1) to enhance positive mood or achieve intoxication, "to get high" (Dixon et al. 1991) , "to feel good" (Fowler et al. 1998) ; (2) to cope with negative emotions, "to decrease depression," "to relax" (Dixon et al. 1991) ; and (3) for social reasons, for example, "something to do with friends" (Test et al. 1989 ) and "to face people better" (Fowler et al. 1998) . A minority reported using substances to relieve symptoms of psychosis and medication side effects such as "to decrease hallucinations," "to relieve side effects of medication" (Addington and Duchak 1997) , and "to decrease suspiciousness" (Test et al. 1989 ), suggesting there is possibly a fourth motive for substance use particular to individuals with psychotic disorders.
Models proposed to explain these findings include Khantzian's self-medication model (1985 Khantzian's self-medication model ( , 1997 , which has been adopted by many authors (Test et al. 1989; Dixon et al. 1991) to explain psychotic individuals' use of substances to alleviate painful affect states. Other authors argue that interpersonal factors are more important and that psychotic individuals use substances primarily for social affiliation purposes (Baigent et al. 1995; Gearon and Bellack 1999) .
An empirically based model that has been overlooked in previous attempts to explain psychotic disordered individuals' motives for substance use is Cox and Klinger's motivational model of alcohol use (1988) . This model suggests that although biochemical, sociocultural, environmental, and contextual factors affect alcohol use, the final common pathway to alcohol use is mediated by cognitive processes. These include thoughts, memories, and perceptions that determine a person's expectations about the direct and indirect effects that alcohol will have on the person's affect. Cooper and colleagues (1992) translated this model into three types of motives: (1) enhancement motives: drinking to enhance positive mood or well-being; (2) social motives: drinking to obtain positive social rewards; and (3) coping motives: drinking to reduce or regulate negative emotions. The motives are captured in the Drinking Motives Questionnaire (DMQ, Cooper et al. 1992) , which has been modified for use with adolescents by the addition of conformity motives (Cooper 1994) . These motives correspond to the three motives reported by individuals with psychotic disorders. Mueser and colleagues (1995) adapted the DMQ (excluding the conformity items) to assess motivations for other drug use (Drug Use Motives Measure [DUMM] ) in a study of 70 inpatients and outpatients who had a diagnosis of schizophrenia or schizoaffective disorder and had used an illicit drug at least once. The three motive subscales were found to be internally reliable with Cronbach's alpha, ranging from 0.74 (socialization motives) to 0.91 (enhancement motives). Mueser and colleagues' findings (1995) provide support for the argument that psychotic individuals' reasons for substance use can be explained by a motivational model. However, the DUMM does not investigate the use of substances to relieve symptoms of psychosis or medication side effects (Warner et al. 1994; Fowler et al. 1998) . Furthermore, it does not contain the conformity items from Cooper's DMQ (1994) , which were separately established as a salient motive for the adolescent population (Cooper 1994) and which might have particular relevance in psychosis, where social development is often arrested (Jackson et al. 1997) .
Previous research examining reasons for substance use in the psychotic population has not established the role of cognitive motivations in maintaining substance use. If such motives do maintain use, then treatments based on understanding these motives, such as relapse prevention and motivational interviewing, are valid. The relationship between mental health symptoms and motives for substance use could also be explored more fully. Research has established correlations between symptoms and motives (Baigent et al. 1995; Fowler et al. 1998 ) and symptoms and substance use (Dixon 1999) . However, if Cox and Klinger's motivational model applies to this population, more severe symptoms should lead to more reasons for use that in turn should lead to heavier use or stronger psychological dependence on the substances used. Motives for use may be the mediator between symptoms and substance misuse-that is, the means by which symptoms exert their influence on substance misuse (Baron and Kenny 1986) .
Current Study
The current study aimed to examine (1) the reasons for substance use among individuals with psychotic disorders through the use of the DMQ (Cooper 1994) , with additional items developed by the authors to explore the use of substances to alleviate psychotic symptoms (positive and negative) and sequelae of the disorder, including medication side effects; (2) the influence these motives for use have on the quantity, context, problems, and dependence associated with substance use; and (3) the role of motives as mediating the relationship between mental health symptoms and problematic substance use.
It was expected that the reasons for use in a psychotic sample would be similar to those in the general population, with the additional motive of using substances to relieve the symptoms of psychosis, medication side effects, and social isolation. Not only would the motives for use predict the quantity, context, problems, and dependence related to substance use, but also in accord with Cox and Klinger's model, motives would be the mediating mechanism by which symptoms lead to substance use. As one of the primary goals was to determine reasons for substance use along a continuum of level of use or misuse in a psychotic sample, whether patients met criteria for a diagnosis of substance abuse or dependence was of less interest.
Method
Participants. Adult inpatients and outpatients served by a major mental health service provider in Western Australia and having a diagnosis of a psychotic disorder (based on DSM-IV [APA 1994 ] criteria) were recruited from inpatient wards, psychiatrists' outpatient clinics, depot medication clinics, and outpatient rehabilitation units. Participants did not have to meet a DSM-IV diagnosis of substance abuse or dependence. However, any patients who had completely abstained from alcohol or drug use for the past year or longer were excluded.
Measures.
A structured interview was developed to assess quantitatively two areas: (1) patterns of substance use, and (2) mental health symptoms.
Patterns of substance use. The SUSP was developed using items from the Opiate Treatment Index (Darke et al. 1992) , the DMQ (Cooper 1994) , the Severity of Dependence Scale (SDS; Gossop et al. 1995) , and the Problems Scale (Kavanagh et al. 1998) .
Section 2 from the Opiate Treatment Index (Darke et al. 1992 ) was included to obtain an estimate of recent use of alcohol and illicit substances. In order to enhance participants' recall, the interviewer asks the individual to recall the last three occasions of use and the quantities used on the first two of these occasions. The intervals between days of drug use and the amounts consumed on these days (over the preceding month only) is computed to estimate recent consumption, resulting in an estimate of daily use for alcohol, cannabis, amphetamines, hallucinogens, cocaine, inhalants, and heroin. (Tobacco use was not measured, as it was not considered to have as adverse an impact on mental health symptoms.) Test-retest reliability of the drug use items is 0.88, and the scale is significantly correlated with the Addiction Severity Index of McLellan and colleagues (1980) (see Darke et al. 1992) .
The remainder of the SUSP focused on the substance most frequently used by the individual. Reasons for use of that substance were assessed with 19 items from the DMQ (Cooper 1994) and an additional 20 items developed by the authors, covering drug use to cope with symptoms of psychotic disorders and sequelae such as medication side effects and social isolation. These additional items were selected from highly endorsed items in published protocols (Test et al. 1989; Dixon et al. 1991; Addington and Duchak 1997; Fowler et al. 1998) . For each reason, subjects rated how often they used their most frequent substance on a five-point scale: never/almost never (0), some of the time (1), half of the time (2), often (3), and almost always/always (4). A pilot study with all questions about reasons for use, conducted with five significant drug users with psychotic disorders, led to a final list of 34 items. Seventeen items remained from the DMQ and 17 items from the additional reasons. The pilot study participants felt that all questions about reasons for use were equally appropriate across all substances. Appendix 1 contains a list of both DMQ and additional items.
The context of subjects' substance use was estimated by items from the Cannabis Use Effects Survey, developed for use with a psychotic population (Rolfe et al. 1998) . It asks how often subjects use the substance of choice in the following contexts: on their own, with friends, with family, with strangers, and in the hospital. Participants respond to these choices on a five-point rating scale ranging from 0 (never) to 4 (always).
Whether subjects were psychologically dependent on their most frequently used substance was established with the SDS (Gossop et al. 1995) . This is a self-report questionnaire asking five questions specifically concerned with the individuals' feelings of impaired control over their own drug taking and with their preoccupation and anxieties about drug taking. Each item is scored on a fivepoint scale with the total score being the sum of ratings over all questions. Higher total scores indicate higher dependence. Test-retest reliability is 0.89 (Gossop et al. 1995) , and total score is related to amount and frequency of use.
Subjects' self-reported problems associated with their most frequently used substance were established from a brief self-report scale developed by Kavanagh and colleagues (1998) and based on measures such as the Drug Abuse Screening Test (Gavin et al. 1989 Preliminary results with a sample of 60 inpatients with substance abuse and early psychosis indicated high internal reliability of 0.89 (David Kavanagh, personal communication, April 7, 1999) .
Motivation to change and confidence to change substance use were estimated by two questions also developed by Kavanagh and colleagues (1998) . Subjects rate their motivation and confidence separately on five-point scales.
Mental health symptoms. Clinical ratings of symptoms were based on items selected from the Positive and Negative Symptoms Scale (PANSS, Kay et al. 1992) to assess the severity of negative, positive, and disorganization symptoms corresponding with the well-accepted three-factor model of symptoms in schizophrenia patients (Liddle 1987 ) and nonschizophrenia patients (Ratakonda et al. 1998) . Seven items were selected to rate the following: delusions, hallucinations, suspiciousness/persecution, conceptual disorganization, blunted affect, lack of spontaneity of flow of conversation, and passive/apathetic social withdrawal. The PANSS has been used extensively in schizophrenia research, including studies examining patterns of substance use (Addington and Duchak 1997) .
Self-reported symptomatology was measured with the Brief Symptom Inventory (BSI, Derogatis 1993 ). This instrument comprises 53 items covering a wide range of psychiatric symptoms. Items are rated on a five-point scale from 0 (not present) to 4 (extremely severe). Scoring yields a global severity index and nine primary symptom dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. The BSI is psychometrically robust and standardized against several large samples.
Self-reported medication side effects were measured with the Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS, Day et al. 1995) . The items include 41 known side effects of neuroleptics and 10 "red herring" items such as hair loss and chilblains, which are not known side effects. These are scored separately to identify individuals who overscore generally on the scale. The side effects score is the total of ratings on all other items. Items are rated on a five-point scale from 0 (not at all) to 4 (very much). Test-retest reliability is 0.8 (Day et al. 1995) .
Procedure. All interviews were carried out by C.S. Case managers, nursing staff, and psychiatrists were asked to identify clients meeting the research criteria who were able to consent to interview. Written consent was obtained prior to commencement of the interview. The project was approved by the University of Western Australia Human Research Ethics Committee and the Fremantle Hospital Ethics Committee.
Measurement instruments were administered in the following order: PANSS, BSI, SUSP, and LUNSERS. Items on self-report questionnaires were read aloud and rating scales provided so that subjects could select the answer. Subjects self-administered the LUNSERS. Case notes were used to obtain information regarding current medication and diagnosis.
Analysis Strategy. Four phases of analysis were undertaken: (1) an examination of patterns of substance use, including an exploratory factor analysis to investigate the factor structure of the "reasons for use" questionnaire and to develop internally reliable motive subscales for use in further analysis; (2) multivariate analysis of variance (MANOVA) examining differences in motive subscales across drug type (cannabis vs. alcohol only); (3) multiple linear regression to investigate the extent to which motives for drug use predict quantity, dependence, problems, and context of use; and (4) mediator analysis to investigate the relationship among mental health symptoms, reasons for use, and substance use.
Results
Participant Characteristics. Of the 83 patients approached, 69 (83%) agreed to participate in the study. The primary reasons for refusal by inpatients were drowsiness or irritability, and for outpatients, time constraints.
The mean age was 31 years (range 18-58). There were 51 males and 18 females and an equal distribution of inpatients and outpatients (34 and 31, respectively). There were 47.8 percent with a diagnosis of schizophrenia and the remainder with a variety of other psychotic disorders (table 1 contains a breakdown of diagnoses). The group had a mean of 3.5 (range 0-17) inpatient admissions and a mean of 5.2 (range 0-31) years as a user of mental health services.
Patterns of Substance Use. The Opiate Treatment Index measure of quantities of each substance gives an estimate of daily use over the last month. It does not, therefore, differentiate drug or alcohol bingers from regular users. Furthermore, the following figures may be an underestimate of use, because 50 percent of participants were interviewed in the hospital, where access to substances was limited. Over the previous month, 77 percent of participants had used alcohol (32% > 1 drink per day, 20% > 3 drinks per day), 50 percent cannabis (22% > 1 joint/cone Note.-NOS = not otherwise specified.
per day, 15% > 2 joints/cones per day), 5 percent amphetamines, 5 percent hallucinogens, 3 percent heroin, and 2 percent inhalants. No participants reported cocaine use in the previous month. As alcohol and cannabis were the only commonly used substances, all subsequent references to substance use among this study sample relate to these two substances only.
Forty-seven percent of participants had engaged in polysubstance use in the past month. Thirty percent of these polysubstance users had recent use amounting to two or more units of substances a day, and 20 percent had use amounting to five or more units a day (one unit = one standard drink/one joint or cone/one hit/one tablet).
Thirty-three percent of participants scored higher than the mean Problems Scale score (Kavanagh et al. 1998 ) observed in a sample with a dual diagnosis (David Kavanagh, personal communication, April 7, 1999) . Twenty-three percent of participants obtained ratings higher than 5 on the dependence scale (Gossop et al. 1995) , where a score of 4 or more is indicative of psychological dependence in a nonpsychiatric population.
Participants had used substances mostly with friends or on their own. Using with family members or strangers or in the hospital was less common. Readiness to change had a mean of 2.14 (± 1.56), indicating on average that respondents were unsure about whether they want to change their substance use. However, participants were confident they could change their substance use if they wanted to (mean of 4.36 [± 0.92]) .
In summary, between 20 percent and 30 percent of the sample used problematic quantities of substances (mostly alcohol and cannabis) or reported psychological dependence on their substance of choice.
Reasons for Substance Use. As there were 34 reasons in total and a sample size of 69, items were screened to reduce the number entered into factor analysis. Items that had proven ambiguous during interviewing and items for which the participants did not use the full range of responses (1-5) were excluded from analysis. Items that were too highly correlated or had zero-order correlations with other items were also removed from the analysis.
A confirmatory principal axis factor analysis was conducted on the 15 remaining items of Cooper's DMQ (1994) only, specifying four factors, with varimax rotation. Analysis resulted in only three factors with eigenvalues greater than one (accounting for 51% of the variance), which was supported by comparison to Cattel's scree plot. These factors were (1) Cooper's "coping" factor (Cronbach's alpha of 0.92), (2) a combination of social motives and enhancement motives (internal reliability of 0.84), and (3) conformity motives with a social motive, "to be sociable" (alpha 0.74). When the second factor was examined for reliability of the two separate motives, social motives and enhancement motives, they had acceptable internal reliability (0.76 and 0.75, respectively) but could not be distinguished given the small sample size.
An exploratory principal components analysis of the 15 items from Cooper's DMQ together with the remaining 11 additional items was undertaken to examine whether "coping with psychotic symptoms and sequelae" represents a distinct factor. A Keyser-Meyer-Olkin statistic of 0.82 indicated very good factorability. All factors with eigenvalues greater than 1 were retained and compared with Cattel's scree plot to determine the number of factors to retain. On this basis, four factors, accounting for 60 percent of the variance, were retained. A further principal component analysis was conducted specifying four factors and rotated via varimax rotation to assist interpretation. The first factor includes most of Cooper's "coping" motives and the majority of negative symptoms as well as racing thoughts and restlessness. This factor was labeled "coping with unpleasant affect." The second factor was Cooper's social motives and enhancement motives items, as found in the first principal components analysis; this was labeled "enhancement." A third factor included Cooper's conformity items (with the exception of "because your friends pressure you to do it") and additional items that represent using drugs to improve social confidence or ability; this factor was labeled "conformity and acceptance." The fourth component contained only one of Cooper's items: "because your friends pressure you to do it." As the remaining items represent using drugs to relieve the more primary positive psychotic symptoms and medication side effects, this factor was labeled "relief of positive symptoms and medication side effects." The full factor solution with eigenvalues and percent of variance explained appears in table 2. The factors were used to create motive subscales for subsequent analyses. Cooper's subscales were kept intact because they have proven to be reliable in previous studies (Cooper 1994; Mueser et al. 1995; Stewart et al. 1996) and because the sample size was not large enough in the current study to justify conclusions regarding a different factor structure. The second factor was therefore separated into two subscales of social motives and enhancement motives in accordance with Cooper's theory (1994) . The factors were converted to subscales by establishing participants' mean scores across subscale items.
Examination of Cronbach's alphas indicates high internal reliability for each of the subscales, apart from "relief of positive symptoms and side effects"; thus, results of subsequent analyses using this variable should be examined with caution. Subscale means in descending order, standard deviations, and Cronbach's alphas are presented in table 3, with items corresponding to each subscale.
Mean differences in motives for drug use across drug type. To identify whether motives differ across substances, a MANOVA was conducted, with five motive subscales as dependent variables and drug type (cannabis vs. alcohol) as the between-group variable. There was a significant main effect for drug type (Wilk's lambda F = 2.70, p < 0.01). Interpretation of the univariate results revealed a significant main effect for drug type on "coping with unpleasant affect" (F = 8.76, p < 0.001), "enhance- ment" (F = 3.54, p < 0.05), and "conformity and acceptance" (F = 3.54, p < 0.001). Cannabis users had significantly greater mean scores for each of these subscales. Average scores for "social motive" and "relief of positive symptoms and side effects" did not differ significantly between alcohol and cannabis users. Motives for substance use as predictors of substance use variables. Multiple linear regressions were undertaken to examine whether participants' motives for the most frequently used substance predicted (1) quantity of that substance used; (2) contexts in which that substance was used; (3) self-reported dependence on that substance; (4) problems associated with that substance; and (5) readiness to change use of that substance. In all regression analyses, predictive relationships were in the expected direction, with positive linear relationships between all motive subscales and all dependent variables.
A single-step multiple regression with motive subscales as predictors of quantity of "recent use" (of the drug for which reasons for use were identified) revealed that the motive subscales accounted for 35 percent of the variance in recent use (R = 0.59, F = 6.31, p < 0.001). Only "coping with unpleasant affect" and "enhancement" subscales were significant predictors.
An examination of the relationship between motives for use and contexts in which substances are used indicated that "using drug with friends" was significantly predicted by motive subscales, accounting for 30 percent of the variance (R = 0.55, F = 5.180, p < 0.001); the "social motive" subscale was the only significant positive predictor. "Using drug with strangers" was significantly predicted by motive subscales, accounting for 35 percent of variance (R = 0.59, F = 6.344, p < 0.001); "enhancement" was the only subscale with a significant standardized coefficient. "Using drugs on own" was significantly predicted by motive subscales, accounting for 37 percent of the variance (/? = 0.61, F = 6.89, p < 0.001); "coping with unpleasant affect" was the only significant subscale.
Motive subscales significantly predicted 57 percent of the variance in "dependence" (R = 0.76, F = 15.667, p < 0.001); "coping with unpleasant affect" and "relief of positive symptoms and medication side effects" were significant positive predictors.
Motives for use of a substance accounted for 47 percent of the variance in "problems" related to the use of that substance (R = 0.68, F = 10.54, p < 0.001). As with quantity of "recent use," only "coping with unpleasant affect" and "enhancement" subscales were significant on examination of standardized coefficients.
Motive subscales predicted 37 percent of the variance in "readiness to change" substance use (R = 0.6, F = 6.86, p < 0.001); "coping with unpleasant affect" was the only significant positive predictor.
In summary, people who are using substances to cope with unpleasant affect or for enhancement purposes are more likely to misuse alcohol and cannabis, as indicated by using large quantities of the substance and having problems associated with that use. People who are using substances to cope with unpleasant affect or to relieve positive symptoms and medication side effects are more likely to be psychologically dependent on those substances.
Mediator analysis. As motives had been shown through regression analysis to be strong predictors of substance use, an examination of whether motives mediate the relationship between symptoms and substance use was undertaken. The mediational model is displayed in figure  1 . To test this model, the following multiple linear regression analyses were conducted in accordance with procedures outlined by Baron and Kenny (1986) : (1) 
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Substance use toms); (2) response variable (substance use) was regressed on predictor variables; and (3) response variable was regressed on both mediator (motives) and predictor (symptoms) simultaneously.
Before we conducted these analyses, appropriate variables had to be selected and examined for normal distribution, multicollinearity, and outliers. As "recent use" of the most frequently used drug was significantly positively skewed, it was decided to use the more widely accepted, valid, and reliable measure of "dependence" (SDS, Gossop et al. 1995) . "Dependence" was correlated with "recent use" (/? = 0.572, p < 0.001) and "problems" (R = 0.786, p < 0.001). There were unacceptable levels of multicollinearity between the three symptom variables: (1) the global severity index of the BSI; (2) total score on positive and negative items of the PANSS; and (3) medication side effects total (LUNSERS). The global severity index of the BSI was selected as an index of symptoms for the following reasons. The BSI contains a psychosis scale (which consists of positive symptoms) and somatization, anxiety, and depression subscales (which contain items similar to those of the LUNSERS). Furthermore, as this study aimed to investigate whether individuals' subjective levels of distress from symptoms lead to stronger motives and dependence, self-reported symptomatology was considered to be more appropriate than clinicianbased ratings. However, the negative symptom total of the PANSS was also selected as a predictor variable to provide a measure of negative symptoms not available from the BSI.
In the first regression analysis for testing the mediational model, "total motives" (a summation of motive subscale means) was regressed on the global severity index of the BSI and negative total of PANSS (path a of figure 1). The symptom variables significantly predicted 24 percent of the variance in motives (/? = 0.49, F(2,57) = 9.15, p < 0.001). Both global severity index and negative PANSS were significant predictors (table 4 contains standardized coefficients). In the second regression analysis, "dependence" was regressed on the global severity index and negative PANSS (path c of figure 1). The symptoms significantly predicted 19 percent of the linear relationship with substance dependence (R = 0.44, F = 6.941, p < 0.01). Examination of the standardized coefficients revealed that global severity index was the only significant predictor (table 4). In the third regression analysis, substance "dependence" was regressed on both the global severity index and "total motives" simultaneously. The global severity index and "total motives" accounted for 47 percent of the linear relationship with "dependence" (R -0.68, F = 25.293, p < 0.001). Examination of the standardized coefficients revealed that "total motives" was the only significant predictor (table 4). Note-GSI = Global Severity Index; PANSS = Positive and Negative Syndrome Scale.
*p < 0.05; "p < 0.01; ***p < 0.001
Results of this analysis meet the conditions, specified by Baron and Kenny (1986) , for mediation to be demonstrated. These conditions are as follows: (1) the independent variable (predictor) must significantly affect the presumed mediator in regression 1 (path a in figure 1) ; (2) the predictor must be shown to affect the dependent (response) variable (path c in figure 1) in regression 2; (3) the mediator must affect the response variable in regression 3 (path b); and (4) the predictor variable must have less of an effect on the response variable than the mediator in regression 3. In addition to the conditions outlined above, the strength of mediation is indicated by the extent of reduction in the predictor's effect on the response variable in the third equation (Baron and Kenny 1986) . Perfect mediation holds if the predictor has no effect on the response variable when the mediator is controlled (Holmbeck 1997) . This is demonstrated by change in the standardized coefficient for global severity index (predictor) in the third regression (table 4) . Motives for substance use are clearly shown to be a significant mediator in the relationship between symptoms and substance dependence.
Limitations. One limitation of this study is the small sample size. This was considered when examining results of the factor analyses. Cooper's subscales were adhered to, because they have been shown to be internally reliable with a psychotic population in previous research (Mueser et al. 1995) . The small data set did not allow for examination of factor invariance across groups, such as diagnosis or drug type. However, high internal reliability of subscales for the whole sample indicates that the subscales are reliable irrespective of whether participants were rating their reasons for alcohol use or cannabis use. The use of a nonpsychotic psychiatric comparison group would allow more conclusive evidence that the findings do represent motives of a psychotic disordered population.
In the current study it was considered important to have a quantitative measure of recent use that could be quickly and reliably reported (Opiate Treatment Index). The disadvantages of this are that it does not provide a DSM-IV diagnosis of substance abuse or dependence. Another disadvantage is that an estimate of daily use over the last month is possibly not a valid measure of problematic substance use for psychotic patients, whose fluctuating finances and mental state may affect the ability to obtain alcohol or other substances regularly. Anecdotal evidence indicated that these individuals are more likely to binge when they have money. For this reason, the SDS (Gossop et al. 1995) was considered to be a better measure of problematic substance use. Scores for "recent use" (Opiate Treatment Index), "dependence," and "problems" were highly correlated, indicating, to some extent, the validity of these instruments in identifying participants with problematic substance use. In summary, because of selection criteria and measurement of degree of substance use, the level of substance use disorders (DSM-IV) cannot be specified. Therefore, extrapolation of these findings to patients with comorbid diagnoses may not be justified. In addition, the findings of this study are limited to alcohol and cannabis use only. The authors are currently undertaking a replication of this study with a sample with comorbid psychosis and substance use disorders (including amphetamine abuse).
Discussion
Overall, the proportion of participants in the current study of individuals with a psychotic disorder who misuse substances is similar to the proportions identified in other Australian studies with this population. In the Fowler and colleagues study (1998) , 26 percent of the sample met a diagnosis of recent substance use disorder, with 60 percent using but not reaching criteria for a substance use disorder. Alcohol, cannabis, and amphetamines (in that order) were the most commonly used substances, as found in the current study.
Reasons for Use. On the whole, factor analysis of DMQ data achieved results similar to those of Cooper (1994) and Stewart and colleagues (1996) from general population samples. DMQ items clustered into three motives: "coping" and "conformity" items loaded onto two separate factors, providing confirmation that these reasons for substance use represent two underlying motives and that conformity is an important motive to consider in the psychotic population. "Enhancement" and "social" items loaded together as one factor. A larger sample size is required to examine the factor structure further. All four motive subscales of the DMQ had high levels of internal reliability (> 0.75), as found by Mueser and colleagues (1995) .
Additional items were developed in this study to examine whether psychotic symptoms and sequelae are encompassed by the four-factor model or whether they represent a distinct factor. The majority of additional items loaded with the "coping" items of the DMQ; this factor was labeled "coping with unpleasant affect." The additional items developed to represent using substances to improve social confidence and social networks loaded with the conformity items of the DMQ; this was labeled "conformity and acceptance." The additional items, which included symptom labels such as "voices" or "paranoia" or "side effects of medication," loaded on a separate factor labeled "relief of positive symptoms and side effects." Although this factor did not have high internal reliability, it is interesting to speculate on why these items represent an additional motive to the four-factor model. All additional items that loaded with Cooper's "coping" items, such as "to decrease restlessness," "to make it easier to sleep," and "to slow down racing thoughts," which were included to represent relief of positive symptoms, could equally be seen as decreasing general anxiety or depression. Previous research has indicated that patients may not be aware of the distinction between primary dysphoria and secondary dysphoria from positive or negative psychotic symptoms and medication side effects (Dixon et al. 1991; Earnst and Kring 1997) . This could explain why items representing use of substances to relieve mental health symptoms clustered into two separate factors. Items that obviously represented positive symptoms and side effects, such as "to get away from the voices" and "to reduce side effects of medication," represent one underlying motive for the psychotic participants, and items describing the relief of general unpleasant affect represent a separate motive. Further research using the DMQ with additional items would benefit from including more items representing obvious attempts to reduce psychotic symptoms and medication side effects, in order to examine whether the additional motive of using to relieve these symptoms is reliable and has predictive validity.
"Enhancement" and "social motive" items from the DMQ loaded onto one factor as in previous analyses and did not load with any additional items developed for the psychotic population. This indicates that using substances to enhance mood or social situations is a motive separate from coping with unpleasant affect.
These results both confirm previous findings (Test et al. 1989; Dixon et al. 1991; Warner et al. 1994; Mueser et al. 1995; Addington and Duchak 1997) related to reasons for substance use and extend them by demonstrating that additional reasons for use specific to individuals with psychotic disorders can be incorporated into the four motive dimensions of "enhancement," "coping," "social," and "conformity." The results of the factor analysis indicate that psychotic disordered individuals have reasons for substance use that are similar to those of the general population (Cooper et al. 1992; Cooper 1994) , with the possibility of an additional motive, "relief of positive symptoms and side effects," thus providing support for a cognitive motivational model of substance use in this population (Cox and Klinger 1988; Cooper 1994) .
Cannabis users had higher scores than alcohol users across all motive subscales, particularly "coping with unpleasant affect," "enhancement," and "conformity and acceptance." This finding can be explained by Cox and Klinger's motivational model of substance use (1988), which specifies that people's motives for use are influenced by thoughts, memories, and perceptions of the direct and indirect effects that drug use will have on their affect. Perhaps cannabis users have greater expectations that cannabis will improve their mood or result in acceptance than alcohol users have about the effects of alcohol. It could also be the case that cannabis induces these changes to affect better than alcohol does. There were few stimulant users in the sample-as with Australians generally. Hence, it is not possible to speculate on how psychotic stimulant users would compare with psychotic alcohol and cannabis users.
Motives Predict Patterns of Substance Use.
Participants' reasons for using substances predicted the amount consumed over the previous month, the context in which they use that substance, the problems associated with using that substance, and the psychological dependence on that substance. These relationships for alcohol and cannabis users vary depending on the type of motive. This pattern of relationships between reasons for use and patterns of use replicates Cooper's (1994) findings with a general population sample. Participants in the current study who used substances for "coping with unpleasant affect" or for "enhancement" used more of those substances. Using for these reasons also leads to more associated problems (i.e., social, personal, and interpersonal problems). The "social motive" does not appear to be influential in the development of problems or heavy use and appears to represent normative, socially acceptable, and socially cued reasons for use (see Cooper 1994) . Similarly, the "conformity and acceptance motive" does not appear to be related to heavy or problematic use among these participants.
Reasons for use also predicted the context in which participants use substances. Using drugs for "coping with unpleasant affect" significantly predicted using the substance on one's own. Using drugs for "social" reasons predicted use with friends.
This study has established the importance of reasons for substance use for increasing psychological dependence on that substance. Using substances for "coping with unpleasant affect" and "relief of positive symptoms and side effects" led to stronger dependence on those substances. Furthermore, people who use substances for "coping with unpleasant affect" have a desire to stop or reduce their substance use. This is important information for treatment purposes.
Reasons for Use Mediate the Relationship Between Mental Health Symptoms and Substance Dependence.
Previous studies have indicated, through correlations or analysis of variance, that there is a significant relationship between symptoms, reasons for use, and substance use disorders. For example, Baigent and colleagues (1995) found that people's reasons for substance use correlated with the global severity index of the BSI, while Fowler and colleagues (1998) found that those subjects with a history of substance abuse or dependence had higher scores on the anxiety subscale and global severity index of the SCL-90-R (Derogatis 1994) . The mediational analysis conducted in the current study has shown that increases in symptoms lead to increases in motives for use, which in turn lead to increased dependence on substances (alcohol or cannabis). Motives are the generative mechanism through which symptoms lead to dependence on cannabis and alcohol; thus, they are the means by which symptoms exert their influence on problematic use of these substances (Baron and Kenny 1986) . These findings apply across the range of quantities of alcohol and cannabis used, irrespective of whether the user met diagnostic criteria for substance abuse or dependence. This provides support for the cognitive motivational model of substance use (Cox and Klinger 1988; Cooper 1994) , which specifies that the final common pathway to substance use is mediated by the expectations people have about the effect that substance use will have on their affect.
The attempt here was not to provide an exhaustive model of why individuals with psychotic disorders use substances. It should be noted that there are other factors such as biochemical reactivity, sociocultural and environmental influences, past reinforcement from drinking, and conditioned reactions to substance use that will influence the decision to use or not to use substances (Cox and Klinger 1988) . Nor can it be asserted that these findings are restricted to patients with psychotic disorders, given the lack of comparison data from a patient group of nonpsychotic individuals.
What the current research has provided is a validation of the cognitive motivational model that allows an understanding of reasons for alcohol and cannabis use that an individual is consciously aware of and the patterns of use that are related to those reasons. The validity of symptoms in predicting reasons for use, which in turn predict stronger substance dependence, disputes the hypothesis that self-reported reasons for use are merely post hoc rationalizations (Miller et al. 1994 ). Clearly, they are important to an understanding of psychotic disordered individuals' substance use, which in turn can inform effective treatments.
Treatment Implications. As the majority of the participants in this study did not meet traditional criteria for substance abuse or dependence, treatment implications for patients meeting these criteria are limited. However, the research has highlighted the influence that reasons for alcohol and cannabis use have on the quantity used, the context of use, and associated problems and psychological dependence. Using substances to cope with unpleasant affect or to enhance positive affect is linked with increased use and substance use problems. Using to cope with unpleasant affect and positive symptoms and side effects is also linked to psychological dependence on substances. These are obviously important perceived benefits and beliefs that maintain these individuals' alcohol and cannabis use. Therefore, testing these beliefs or providing individuals with alternative ways to achieve these effects is an important component of treatment. This provides validation for cognitive-behavioral treatments that address motives for substance use. An example is Graham's (1998) treatment model, which proposes that reasons for use become dysfunctional beliefs regarding the need for substances, thus maintaining use, regardless of effects. The treatment involves helping individuals to identify their substance-related beliefs, test those beliefs, and identify alternatives. There is also a focus on relapse prevention and strategies to improve self-concept and selfesteem. Similar treatments are being used with success in some of the current treatments for comorbid substance use and psychosis (Kavanagh 1995; Seigfreid 1998; Gearon and Bellack 1999) .
This research indicates that psychotic disordered individuals who use alcohol or cannabis to cope with unpleasant affect have a higher readiness to change their use than those who use for social or conformity purposes, enhancement, or relief of positive symptoms and side effects. These differences in readiness to change can inform the appropriate selection of interventions (Zeidonis and Fisher 1994) . Those using to cope may require assistance to reduce use or prevent relapse. Others may require more motivational enhancement.
Conclusion
The current research has provided empirical support for a motivational model of psychotic disordered individuals' substance use (primarily alcohol and cannabis use). The final common pathway to their substance use is the expectation that substances will have direct or indirect changes on their affect. Specifically, these people-like the population in general-use cannabis and alcohol to cope with unpleasant affect, enhance their affect, socialize, or be accepted by their peers. The research indicates an additional motive for the psychotic population, which is to relieve positive symptoms and medication side effects. However, the low endorsement of this additional motive indicates that these people are less likely to use for this reason. The DMQ (Cooper 1994) , with additional items developed for this research, will be a useful tool for further research and treatment. The utility of cognitivebehavioral treatments to reduce substance use has been validated by the current research, which demonstrated that reasons for use predict patterns of substance use and also mediate the relationship between mental health symptoms and substance dependence. Coping motives have been demonstrated to be most linked to problematic substance use and a willingness to change. Treatment should, therefore, be targeted toward this motive.
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